Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$850.10M
Total Bought:
$182.90M
Total Sold:
$238.24M
Net Transaction:
-$55.34M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Newamsterdam Pharma Company
ORDINARY SHARES
10,473,91310,719,110+245,197$173.87M$275.48M32.41%+$101.61M
Nuvalent Inc2,697,2671,447,267-1,250,000$275.93M$113.29M13.33%-$162.64M
Pharvaris N V
COM
3,303,3813,303,3810$61.18M$63.33M7.45%+$2.15M
Disc Medicine, Inc.(IRON)1,795,735983,500-812,235$88.24M$62.35M7.33%-$25.89M
Dianthus Therapeutics, Inc.(DNTH)3,013,4232,689,707-323,716$82.51M$58.64M6.90%-$23.87M
Savara Inc.(SVRA)14,565,45714,565,4570$61.76M$44.72M5.26%-$17.04M
Olema Pharmaceuticals, Inc.(OLMA)07,470,214+7,470,214$0$43.55M5.12%+$43.55M
Upstream Bio, Inc.(UPB)02,295,322+2,295,322$0$37.74M4.44%+$37.74M
Annexon, Inc.(ANNX)8,449,7485,249,069-3,200,679$50.02M$26.93M3.17%-$23.09M
Cidara Therapeutics Inc703,080703,0800$7.56M$18.90M2.22%+$11.34M
Solid Biosciences Inc4,034,5824,034,5820$28.12M$16.14M1.90%-$11.98M
Kyverna Therapeutics, Inc.(KYTX)3,368,3703,368,3700$16.47M$12.60M1.48%-$3.87M
X4 Pharmaceuticals, Inc.(XFOR)16,915,78416,915,7840$11.32M$12.41M1.46%+$1.09M
Mersana Therapeutics Inc8,663,6738,663,6730$16.37M$12.39M1.46%-$3.99M
Tango Therapeutics, Inc.(TNGX)2,712,0082,712,0080$20.88M$8.38M0.99%-$12.50M
Atea Pharmaceuticals, Inc.(AVIR)2,485,6382,485,6380$8.33M$8.33M0.98%$0
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$7.51M$7.59M0.89%+$84.3K
Cabaletta Bio, Inc.(CABA)2,760,8882,760,8880$13.03M$6.27M0.74%-$6.76M
Century Therapeutics, Inc.(IPSC)5,410,3615,410,3610$9.25M$5.46M0.64%-$3.79M
Xilio Therapeutics, Inc.(XLO)4,566,8174,566,8170$3.60M$4.36M0.51%+$764.0K
C4 Therapeutics, Inc.(CCCC)1,111,9101,111,9100$6.34M$4.00M0.47%-$2.34M
Nautilus Biotechnology, Inc.(NAUT)2,000,0001,759,000-241,000$5.70M$2.96M0.35%-$2.74M
Marinus Pharmaceuticals Inc2,693,3802,693,3800$4.74M$1.44M0.17%-$3.30M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
100,000100,0000$700.0K$1.43M0.17%+$725.0K
Invivyd, Inc.(IVVD)1,799,5951,799,5950$1.84M$797.4K0.09%-$1.04M
Syros Pharmaceuticals Inc2,750,1512,750,1510$5.91M$632.0K0.07%-$5.28M
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q4 2024 | TickerTrail